Evagelos Coskinas, MD
Psychiatry · Riverside, CANPI 1437382314
Payments from drug & device makers
Across 686 payments — averaging $10,599 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$4.7M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.3M
- AbbVie$417K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$262K
- Boehringer Ingelheim$195K
- Teva Pharmaceuticals USA, Inc.$168K
- plus $227K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 16 | $4,748,281 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 387 | $1,253,475 |
| AbbVie | 30 | $417,209 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $261,896 |
| Boehringer Ingelheim | 2 | $194,912 |
| Teva Pharmaceuticals USA, Inc. | 47 | $168,230 |
| Bioxcel Therapeutics, Inc. | 11 | $76,946 |
| Sumitomo Pharma America, Inc. | 72 | $66,933 |
| Merck | 3 | $29,916 |
| Axsome Therapeutics, Inc. | 10 | $23,586 |
| Acadia Pharmaceuticals Inc | 67 | $20,318 |
| Genentech, Inc. | 2 | $5,460 |
| Boehringer Ingelheim RCV GmbH & Co KG | 18 | $3,236 |
| Livanova USA, Inc. | 3 | $298 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Alkermes, Inc. | 3 | $67 |
| Johnson & Johnson | 2 | $52 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Indivior Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
How this compares
$7,270,981 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Riverside
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.